S H Kelkar & Company Q1 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹1,821 Cr
- P/E
- 38.56
- ROE
- 3.71%
- PEG
- -3.53
- Price to sales
- 0.73
- Debt to equity
- 0.76
- 52W high / low
- ₹226 / ₹112
- Sales growth (5Y)
- 12.37%
- EBITDA margin
- 10.46%
- Net profit margin
- 2.06%
- Promoter holding
- 54.87%
- Sales (last year)
- ₹2,450 Cr
Guidance scorecard · Q1 FY27 call
What S H Kelkar & Company Ltd's management guided
and where it ranks in Chemicals & Petrochemicals
Chemicals & Petrochemicals
RevenueQ1 FY27 call
10–20%- The company targets double-digit revenue growth for FY 2027, with some quarterly variations expected due to geopolitical and demand timing factors.
- Flavours segment achieved Rs. 112 crore in Q1, with a normalized run rate estimated around Rs. 95-96 crore from Q2 onwards; growth expected to be strong but not at Q1 levels due to inventory prepayments.
- Fragrance segment sees growth opportunities, especially in new markets like Europe (Germany), USA, and UK, with expected breakeven in 3 years and subsequent fast growth.
- New initiatives in Europe and the USA show traction, aiming for $100 million market capture over next few years.
- Investments in R&D and CDCs to support sustained growth and product innovation.
2 more points from S H Kelkar & Company Ltd's call on revenue
Create a free account to keep reading this call
MarginsQ1 FY27 call
FlatSee what S H Kelkar & Company Ltd said on margins — free account, 30 seconds.
CapexQ1 FY27 call
Planned- Completed European capex with the plant operational since May; Rs. 25 crore spent in Europe in Q1 FY27.
- Ongoing capex in India focusing on Vanvate and Vashivali fragrance projects; Rs. 25 crore planned for Vanvate in Q2 and approximately Rs. 50 crore remaining for three plants in India.
- Vanvate factory expected to be operational by Q3 FY27.
- Decision pending on whether the remaining Rs. 25 crore for Vashivali plant upgradation will be spent in Q4 FY27 or deferred to next year.
- The company is investing roughly $3 million annually in R&D to support growth.
2 more points from S H Kelkar & Company Ltd's call on capex
Create a free account to keep reading this call
FundraisingQ1 FY27 call
None plannedSee what S H Kelkar & Company Ltd said on fundraising — free account, 30 seconds.
Order bookQ1 FY27 call
Rising- In Q1 FY 2027, there was a higher-than-expected sales number in the Flavours segment, partly due to client preponement and extra stock buildup (approx. Rs. 15 crore).
- This Rs. 15 crore reflects additional inventory rather than final consumption.
- The base regular orderbook for Flavours is estimated around Rs. 95-97 crore per quarter.
- Going forward, Q2 and subsequent quarters are expected to normalize with Flavours around Rs. 95-96 crore, potentially slightly higher but not at the Q1 level of Rs. 112 crore.
- No new segments or large global account orders are currently significant.
- Business remains normal with double-digit growth overall.
- USA and UK markets are at early stages; expected minimum revenue from USA is Rs. 1.5 to 2 million for the year.
2 more points from S H Kelkar & Company Ltd's call on the order book
Create a free account to keep reading this call
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Chemicals & Petrochemicals companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 0–2% | ₹263 Cr | 3.4 | |
| 2 | 40%+ | Flat | ₹4,375 Cr | 83.7 | |
| 3 | 40%+ | Flat | ₹3,259 Cr | 4.0 | |
| 4 | 40%+ | Flat | ₹145 Cr | 15.9 | |
| 5 | 20–40% | Up 2%+ | ₹1.81L Cr | 90.9 | |
| 6 | 20–40% | Up 2%+ | ₹48,366 Cr | 78.3 |
Sign up free to see every company in the sector ranking and track S H Kelkar & Company Ltd.
Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals rankingFinancials of S H Kelkar & Company Ltd
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of S H Kelkar & Company Ltd
Quarterly Results
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 472.43 | 422.56 | 455.44 | 471.68 | 513.34 | 470.31 | 542.50 | 543.21 | 567.38 | 580.63 | 553.89 | 583.80 | 649.94 |
| Expenses + | 405.18 | 354.61 | 383.81 | 395.82 | 423.80 | 392.05 | 462.38 | 479.56 | 493.95 | 507.62 | 501.50 | 528.46 | 589.91 |
| Operating Profit | 67.25 | 67.95 | 71.63 | 75.86 | 89.54 | 78.26 | 80.12 | 63.65 | 73.43 | 73.01 | 52.39 | 55.34 | 60.03 |
| OPM % | 14.23% | 16.08% | 15.73% | 16.08% | 17.44% | 16.64% | 14.77% | 11.72% | 12.94% | 12.57% | 9.46% | 9.48% | 9.24% |
| Other Income + | -20.44 | 1.62 | 1.80 | 1.90 | -0.18 | -120.29 | 20.65 | 0.89 | 61.15 | 3.04 | 1.06 | 34.19 | 8.23 |
| Interest | 7.47 | 9.82 | 9.95 | 10.35 | 10.04 | 9.89 | 12.82 | 13.82 | 12.89 | 13.07 | 13.91 | 13.50 | 15.03 |
| Depreciation | 20.52 | 20.85 | 22.31 | 21.68 | 22.03 | 22.49 | 24.18 | 23.35 | 24.68 | 26.37 | 27.38 | 26.99 | 38.63 |
| Profit before tax | 18.82 | 38.90 | 41.17 | 45.73 | 57.29 | -74.41 | 63.77 | 27.37 | 97.01 | 36.61 | 12.16 | 49.04 | 14.60 |
| Tax % | 94.00% | 28.46% | 26.74% | 29.74% | 41.65% | 16.68% | 37.57% | 36.02% | -5.67% | 30.21% | 24.59% | 33.46% | 87.67% |
| Net Profit + | 1.13 | 27.83 | 30.16 | 32.13 | 33.43 | -86.82 | 39.81 | 17.51 | 102.51 | 25.55 | 9.17 | 32.63 | 1.80 |
| EPS in Rs | 0.17 | 1.96 | 2.12 | 2.33 | 2.45 | -6.25 | 2.87 | 1.27 | 7.41 | 1.85 | 0.66 | 2.36 | 0.13 |
Financials of S H Kelkar & Company Ltd
Profit & Loss
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 834 | 925 | 981 | 1,021 | 1,048 | 1,114 | 1,322 | 1,564 | 1,687 | 1,841 | 2,123 | 2,368 |
| Expenses + | 716 | 774 | 814 | 862 | 908 | 955 | 1,083 | 1,350 | 1,469 | 1,537 | 1,828 | 2,126 |
| Operating Profit | 119 | 151 | 167 | 159 | 141 | 160 | 239 | 215 | 217 | 304 | 296 | 242 |
| OPM % | 14% | 16% | 17% | 16% | 13% | 14% | 18% | 14% | 13% | 17% | 14% | 10% |
| Other Income + | 25 | 10 | 12 | 13 | 21 | -28 | 36 | 6 | -8 | 5 | -38 | 45 |
| Interest | 19 | 22 | 6 | 5 | 16 | 26 | 20 | 16 | 24 | 40 | 49 | 56 |
| Depreciation | 29 | 30 | 19 | 24 | 31 | 52 | 62 | 72 | 80 | 86 | 95 | 119 |
| Profit before tax | 94 | 110 | 153 | 143 | 115 | 54 | 194 | 132 | 104 | 183 | 114 | 112 |
| Tax % | 26% | 34% | 31% | 35% | 24% | 34% | 26% | -13% | 40% | 32% | 36% | 38% |
| Net Profit + | 70 | 73 | 105 | 94 | 88 | 36 | 144 | 149 | 63 | 124 | 73 | 69 |
| EPS in Rs | 5.32 | 5.05 | 7.25 | 6.49 | 6.12 | 2.53 | 10.24 | 10.73 | 4.42 | 8.84 | 5.29 | 5.00 |
| Dividend Payout % | 28% | 30% | 24% | 27% | 0% | 38% | 17% | 7% | 45% | 8% | 19% | 0% |
Financials of S H Kelkar & Company Ltd
Balance Sheet
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 132 | 145 | 145 | 145 | 145 | 141 | 141 | 138 | 138 | 138 | 138 | 138 |
| Reserves | 368 | 571 | 667 | 712 | 719 | 683 | 810 | 875 | 926 | 1,074 | 1,134 | 1,223 |
| Borrowings + | 252 | 85 | 74 | 172 | 342 | 365 | 518 | 698 | 620 | 666 | 832 | 1,029 |
| Other Liabilities + | 187 | 201 | 187 | 246 | 222 | 277 | 405 | 568 | 518 | 502 | 556 | 522 |
| Total Liabilities | 939 | 1,003 | 1,073 | 1,275 | 1,427 | 1,466 | 1,874 | 2,279 | 2,202 | 2,381 | 2,660 | 2,913 |
| Fixed Assets + | 274 | 227 | 296 | 352 | 462 | 472 | 741 | 959 | 914 | 933 | 953 | 1,188 |
| CWIP | 10 | 18 | 7 | 60 | 38 | 18 | 28 | 9 | 26 | 13 | 46 | 90 |
| Investments | 0 | 35 | 50 | 96 | 97 | 97 | 1 | 1 | 23 | 10 | 11 | 11 |
| Other Assets + | 655 | 722 | 720 | 767 | 830 | 879 | 1,103 | 1,309 | 1,239 | 1,425 | 1,650 | 1,623 |
| Total Assets | 939 | 1,003 | 1,073 | 1,275 | 1,427 | 1,466 | 1,874 | 2,279 | 2,202 | 2,381 | 2,660 | 2,913 |
Financials of S H Kelkar & Company Ltd
Cash Flows
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 62 | 86 | 102 | 103 | 77 | 205 | 195 | 50 | 197 | 107 | 16 | 263 |
| Cash from Investing Activity + | -17 | -77 | -103 | -162 | -138 | -42 | -148 | -134 | -110 | -84 | -69 | -205 |
| Cash from Financing Activity + | -7 | -24 | -16 | 28 | 49 | -196 | 88 | 12 | -175 | 8 | 99 | -158 |
| Net Cash Flow | 37 | -14 | -17 | -31 | -12 | -33 | 135 | -71 | -88 | 32 | 46 | -100 |
| Free Cash Flow | 40 | 63 | 64 | -17 | -39 | 161 | 165 | 52 | 149 | 47 | -80 | 60 |
| CFO/OP | 76% | 84% | 89% | 87% | 81% | 146% | 87% | 52% | 109% | 55% | 24% | 135% |
Financials of S H Kelkar & Company Ltd
Ratios
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 85 | 90 | 81 | 99 | 99 | 104 | 103 | 108 | 95 | 97 | 87 | 98 |
| Inventory Days | 252 | 239 | 247 | 233 | 239 | 201 | 216 | 225 | 228 | 243 | 227 | 184 |
| Days Payable | 76 | 116 | 78 | 104 | 86 | 103 | 125 | 143 | 138 | 132 | 126 | 92 |
| Cash Conversion Cycle | 261 | 213 | 250 | 228 | 252 | 202 | 195 | 190 | 185 | 209 | 187 | 190 |
| Working Capital Days | 70 | 135 | 128 | 110 | 86 | 55 | 91 | 90 | 88 | 63 | 62 | 38 |
| ROCE % | 14% | 17% | 19% | 17% | 12% | 10% | 15% | 10% | 8% | 12% | 10% | 6% |
Guidance history
How S H Kelkar & Company Ltd's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q1 FY27 call → | 10–20% | Flat | Planned | None planned | Rising |
| Q4 FY26 call → | 10–20% | Flat | Planned | Planned | — |
| Q3 FY26 call → | 10–20% | — | Planned | — | — |
| Q2 FY26 call → | 10–20% | Up 2%+ | Planned | None planned | — |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
10 out of 100 — Cooling
Over the past year its share price has done worse than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | −42.3% | 9% |
| Last 6 months | −10.6% | 36% |
| Last 3 months | −23.2% | 11% |
The price is 61.7% below its all-time high of ₹341.35 (2 Sept 2016). Stocks more than 20% below their peak have their score halved, so 20 became 10.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For S H Kelkar & Company Ltd: 0.4 × 9 + 0.4 × 36 + 0.2 × 11 = 20, halved to 10 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 29 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What S H Kelkar & Company Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q4 FY25 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY23 earnings call →
Others in Chemicals & Petrochemicals this season
- POCL Enterprises Ltd (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Deepak Nitrite Ltd (Q2 FY27)
Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese
- Privi Speciality Chemicals Ltd (Q2 FY27)
19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks
- NOCIL Ltd (Q2 FY27)
427 crores . Key investor presentation takeaways from NOCIL Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.